ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Kansas City, KS

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Type 2 Diabetes Mellitus
Diabetes Mellitus
Obesity
Type 1 Diabetes Mellitus
Overweight
Diabetic Foot
Foot Ulcer

Diabetes trials near Kansas City, KS, USA:

Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus

This study is a Phase 2 clinical trial to evaluate the efficacy, safety, and tolerability of HM15275 in subjects with type 2 diabetes mellit...

Enrolling
Type 2 Diabetes Mellitus
T2DM
Drug: HM15275
Drug: Placebo of HM15275

Phase 2

Hanmi Pharmaceutical
Hanmi Pharmaceutical

Kansas City, Missouri, United States and 9 other locations

placebo-controlled, multicenter to evaluate the efficacy, safety, and tolerability of AZD6234 in adults with overweight or obesity and type 2 diabetes...

Active, not recruiting
Diabetes, Type II
Obesity
Drug: AZD6234
Drug: Placebo to match

Phase 2

AstraZeneca
AstraZeneca

Kansas City, Missouri, United States and 17 other locations

The goal of this clinical trial is to test a drug known as DFMO in people with Type 1 Diabetes (T1D). The main question\[s\] it aims to answ...

Active, not recruiting
Type 1 Diabetes
Drug: DFMO
Drug: Placebo

Phase 2

Emily K. Sims

Kansas City, Kansas, United States and 6 other locations

This study is a Phase 1b/2a First-in-Human (FIH) clinical trial to assess the safety, tolerability, pharmacodynamics (PD), and efficacy of multiple a...

Enrolling
Type 1 Diabetes Patients
Type 1 Diabetes Mellitus
Drug: CNP-103
Drug: Placebo

Phase 1, Phase 2

COUR Pharmaceuticals

Kansas City, Missouri, United States and 33 other locations

This is a Phase 3 trial of cadisegliatin as adjunctive therapy to insulin in participants with Type 1 Diabetes Mellitus....

Enrolling
Diabetes Mellitus, Type 1
Drug: Cadisegliatin 800 mg QD
Drug: Placebo

Phase 3

vTv Therapeutics
vTv Therapeutics

Lenexa, Kentucky, United States of America and 59 other locations

study medicine to help adults with obesity or overweight and type 2 diabetes lose weight. Being overweight or obese means carrying too much ...

Enrolling
Diabetes, Type 2
Type 2 Diabetes
Drug: PF-08653944
Other: Placebo

Phase 3

Pfizer
Pfizer

Independence, Missouri, United States and 182 other locations

control clinical trial testing two different JAK Inhibitors abrocitnib, ritlecitinib, and placebo in subjects with recent onset Stage 3 Type 1 Diabetes...

Active, not recruiting
Diabetes Mellitus, Type 1
Drug: Ritlecitinib
Drug: Abrocitinib 200 MG Oral Tablet

Phase 2

National Institutes of Health (NIH)
National Institutes of Health (NIH)

Kansas City, Missouri, United States and 29 other locations

The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight.

Active, not recruiting
Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
Drug: Maridebart cafraglutide
Drug: Placebo

Phase 3

Amgen
Amgen

Kansas City, Missouri, United States and 187 other locations

parallel-arm study to evaluate the efficacy, safety and tolerability of SAB 142 in patients with Stage 3 New Onset of Type 1 Diabetes (NOT1D...

Enrolling
Type 1 Diabetes
Drug: Low Dose SAB-142
Other: Placebo

Phase 2

Sab Biotherapeutics

Kansas City, Missouri, United States and 70 other locations

This is a randomized, masked, active-controlled, parallel-group, multi-center study that will assess the efficacy of ILUVIEN as a baseline therapy in...

Active, not recruiting
Diabetic Macular Edema
Drug: Aflibercept
Drug: Iluvien 0.19 MG Drug Implant

Phase 4

Alimera Sciences

Shawnee Mission, Kansas, United States and 39 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems